Addressing One of Healthcare’s Largest Problems
The rapid emergence of resistant bacteria is endangering the efficacy of antibiotics, thus causing a serious threat to global health care.
Each year in the US alone, at least 2 million people become infected with drug-resistant bacteria, and 23,000 people die as a direct result.
ArcDia’s mariAST® is the most promising diagnostic platform to tackle antibiotic resistance. It is rapid, easy-to-use and cost-effective. mariAST allows near-patient analysis directly from clinical samples without isolation of the bacteria strain.
ArcDia’s mariAST® is based on ArcDia’s mariPOC® field-proven test system. The mariPOC® product line for multianalyte testing of acute infections covers viruses and bacteria for the most common respiratory infections and for gastroenteritis.
Watch mariAST video at Youtube, Tudou
13th – 16th April 2019 ECCMID, Amsterdam, Netherlands
See you in Amsterdam, ECCMID 2019. Information about the posters to be announced later.
Read more →
mariPOC® ensures lower probability for C. difficile misdiagnosis with precision
mariPOC® ensures lower probability for C. difficile misdiagnosis with precision mariPOC® CDI test is a…
Read more →“The automated test system mariPOC® enables the detection of 8 respiratory viruses in 2 hours with minimal sample processing and covers viruses for which there are little or no other rapid antigen test available.”